Canada · Health Canada Drug Product Database

COMBANTRIN ORAL SUSPENSION 50MG/ML

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
12925
DIN
01944355
Form
Suspension
Company as listed by source
MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Source status
Cancelled Post Market (2026-03-03)
Source last updated
2026-03-12

Source-listed ingredients

  • PYRANTEL (PYRANTEL PAMOATE) — 50 MG — per 1 ML

These values do not establish equivalence or a dose recommendation.

Packages

  • 45ml

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →
COMBANTRIN ORAL SUSPENSION 50MG/ML — Canada | Molindra Medicines